lung cancer screening
Exciting Data Reveal: Guardant Health (NASDAQ: GH) Shows 43.9% of 20,000 Patients Prefer Blood Tests!
Guardant Health is changing the way we think about cancer screening. They’ve announced new findings about their blood-based test, Shield, ... Read more
Qure.ai Strengthens Leadership Team with Lung Health Expert to Drive Global Clinical Innovation
Dr. Javier J. Zulueta Takes the Helm at Qure.ai Qure.ai just appointed Dr. Javier J. Zulueta as their new Chief ... Read more
